Sterility and bacterial endotoxin tests address different contamination risks. One looks for viable microorganisms under defined test conditions. The other detects or quantifies endotoxin activity associated with Gram-negative bacteria. Passing either test never guarantees passing the other.
Sterility Testing vs. Endotoxin Testing
Sterility and bacterial endotoxin tests address different contamination risks. One looks for viable microorganisms under defined test conditions. The other detects or quantifies endotoxin activity associated with Gram-negative bacteria. Passing either test never guarantees passing the other.
Important context: This article is for scientific and analytical education. A laboratory result does not establish regulatory approval or suitability for human use. Research-use-only materials should be handled only in properly controlled research environments according to applicable laws, institutional requirements, validated procedures, and qualified professional oversight.
The Central Difference
Sterility testing asks:
Were viable contaminating microorganisms detected in the tested sample under the specified culture conditions and observation period?
Endotoxin testing asks:
Was bacterial endotoxin activity detected or quantified above a defined limit using a suitable bacterial endotoxins test?
The distinction matters because microorganisms and endotoxins behave differently. Viable organisms can reproduce when conditions support growth. Endotoxins are nonliving molecular components associated with the outer membrane of Gram-negative bacteria. They can remain after the bacteria that produced them have died or been removed.
A sterilization process may kill viable microorganisms without reliably removing or destroying endotoxin. Conversely, a material can have a low endotoxin result while still containing viable bacteria, yeast, or mold that are not Gram-negative endotoxin sources.
Most common misconception: “Sterile” and “endotoxin-free” are not synonyms. They represent different quality attributes that require different controls and different analytical tests.
What Sterility Testing Evaluates
Sterility testing is designed to detect viable contaminating microorganisms in a defined portion of a product or material. Compendial sterility procedures typically expose the test article to culture media selected to support the growth of a broad range of aerobic and anaerobic bacteria, yeasts, and molds.
The sample is incubated under specified conditions and observed for evidence of microbial growth. A test result may be reported as “no growth,” “complies,” “passes,” or similar language when no evidence of growth is detected under the method conditions.
What sterility testing can detect
- Viable bacteria capable of growing under the selected conditions
- Viable yeast and mold capable of growing in the selected media
- Contamination present in the sampled units at a detectable level
- A sterility failure when growth is confirmed and attributable to the product sample
What a sterility test does not directly measure
- Bacterial endotoxin concentration
- Non-bacterial pyrogens
- Dead microorganisms
- Microbial fragments that cannot reproduce
- Viruses, unless a separate suitable test is used
- Every microorganism that may require specialized growth conditions
- Sterility of every vial in a batch
- Quality of the entire manufacturing process by itself
“No growth” is not proof that zero organisms existed anywhere
Sterility testing is destructive and therefore performed on a sample rather than every finished unit. A negative result means no viable microorganisms were detected in the tested sample under the specified conditions. It does not mathematically prove that every unit in the batch is sterile.
This is why modern sterility assurance depends on much more than the final test. Facility design, environmental monitoring, validated sterilization or aseptic processing, personnel practices, filtration controls, container-closure integrity, process simulations, raw-material controls, and investigations all contribute to confidence in a sterile product.
What Bacterial Endotoxin Testing Evaluates
Bacterial endotoxins are lipopolysaccharide-containing materials associated with the outer membrane of Gram-negative bacteria. They can produce strong biological responses and are an important quality concern for parenteral drug products, biological products, medical devices, and other materials where endotoxin exposure is relevant.
The Bacterial Endotoxins Test (BET) detects or quantifies endotoxin activity using a reagent system that responds to endotoxin. Traditional compendial methods use amebocyte lysate reagents. Newer compendial approaches also include recombinant reagent techniques.
What endotoxin testing can evaluate
- Whether endotoxin activity is detected above the method threshold
- The approximate endotoxin concentration under a quantitative method
- Whether a sample meets a defined endotoxin limit
- Whether the sample matrix interferes with the assay when suitability controls are included
What endotoxin testing does not directly measure
- Viable bacteria, yeast, or mold
- Sterility
- Every possible microbial toxin
- Every non-endotoxin pyrogen
- Identity or purity of a peptide
- Peptide quantity or labeled milligrams
- Regulatory approval or suitability for human use
Why dead bacteria can still matter
A process that kills Gram-negative bacteria may stop them from reproducing but leave endotoxin behind. Endotoxin can be comparatively resistant to ordinary sterilization conditions, and depyrogenation generally requires separate validated controls. Therefore, a material can produce no microbial growth during sterility testing yet still contain unacceptable endotoxin activity.
Key distinction: Sterilization is intended to control viable microorganisms. Depyrogenation is intended to reduce or remove pyrogenic contamination, including bacterial endotoxins, to an established level. The terms should not be used interchangeably.
Why a Sample Can Pass One Test and Fail the Other
Scenario 1: Sterility passes, endotoxin fails
A Gram-negative bacterial contamination event occurs during manufacturing. A later treatment kills the viable bacteria, so the sterility test shows no growth. Endotoxin released from the bacterial cells remains, producing a result above the specified endotoxin limit.
Scenario 2: Endotoxin passes, sterility fails
The sample is contaminated by a viable yeast, mold, or Gram-positive bacterium. These organisms are not measured by a bacterial endotoxins test in the same way as Gram-negative endotoxin, so the endotoxin result can remain low while a sterility culture shows growth.
Scenario 3: Both tests pass
No viable microorganisms are detected in the sampled units, and endotoxin activity is below the defined limit. This is the desired outcome, but it remains limited to the methods, sample plan, detection capability, and validity of the testing process.
Scenario 4: Both tests fail
Viable Gram-negative bacteria are present in the tested sample and produce sufficient endotoxin activity to exceed the limit. Both microbial growth and an elevated endotoxin result may be observed.
Common Sterility-Test Methods
Compendial sterility testing commonly uses either membrane filtration or direct inoculation. The appropriate method depends on the sample’s physical properties, volume, antimicrobial activity, filterability, and compatibility with the test system.
Membrane filtration
The sample is passed through a sterile membrane that retains microorganisms. The membrane is rinsed when appropriate and transferred to growth media. This approach can help remove product components that interfere with microbial recovery.
Direct inoculation
A defined quantity of sample is added directly to suitable culture media. The sample volume must not prevent microbial growth or overwhelm the medium.
Method suitability
The method must demonstrate that the product does not inhibit the recovery of microorganisms under the chosen conditions. Neutralization, dilution, or rinsing may be required.
Culture media and incubation
Sterility methods use growth media and incubation conditions intended to recover different categories of microorganisms. Media must pass growth-promotion testing, and the test environment must minimize the risk that laboratory handling introduces false-positive contamination.
The incubation period is intentionally long enough to allow low numbers of stressed or slow-growing organisms to become detectable. Results should not be interpreted before the required observation period is complete unless a validated rapid microbiological method is being used under an appropriate framework.
Why a positive result requires investigation
Microbial growth can originate from the tested product, the manufacturing process, or an accidental contamination event during laboratory testing. A valid investigation examines the organism identity, test controls, environmental monitoring, analyst practices, equipment, media, sample handling, and manufacturing history.
Simply repeating a failed sterility test until a passing result appears is not scientifically sound. A confirmed initial failure can indicate a serious process problem and must not be dismissed without a justified investigation.
Common Bacterial Endotoxin Test Methods
Bacterial endotoxin methods use a biological reaction cascade that responds to endotoxin. Traditional methods use Limulus amebocyte lysate (LAL) or related lysate reagents. USP Chapter <86>, which became official in May 2025, provides additional techniques using recombinant reagents.
| Method | Basic principle | Typical output | Important considerations |
|---|---|---|---|
| Gel-clot | A clot forms when endotoxin activity reaches or exceeds the reagent sensitivity. | Qualitative or semi-quantitative pass/fail result | Visual endpoint, reagent sensitivity, inhibition or enhancement controls |
| Kinetic turbidimetric | The assay measures increasing turbidity over time as the reaction proceeds. | Quantitative endotoxin concentration | Standard curve, timing, optical interference, reaction kinetics |
| Chromogenic | The activated cascade releases a colored compound measured photometrically. | Endpoint or kinetic quantitative result | Product color, optical interference, standard curve, dilution |
| Recombinant Factor C or cascade reagents | Recombinant proteins reproduce all or part of the endotoxin-responsive pathway. | Usually quantitative fluorescence or color response | Method qualification, product suitability, compendial or regulatory framework |
Endotoxin units
Endotoxin results are commonly expressed in endotoxin units (EU), such as EU/mL, EU/mg, or EU per device. The acceptable limit depends on the product, route, maximum exposure, and applicable standards. A bare number without units or an acceptance limit is not enough to determine whether a result is acceptable.
Product interference must be evaluated
Some sample matrices can inhibit the endotoxin reaction and create falsely low results. Others can enhance the response and create falsely high results. Method-suitability or inhibition/enhancement studies are therefore critical. Positive product controls demonstrate whether a known amount of endotoxin can be recovered in the presence of the sample.
Diluting a sample can reduce interference, but dilution cannot exceed the maximum valid dilution established for the test. Excessive dilution could reduce endotoxin below the method’s ability to detect a meaningful failure.
“Below detection” is not the same as zero
A result such as <0.05 EU/mL means endotoxin activity was not quantified above the stated threshold under the method conditions. It does not mean absolute absence of every endotoxin molecule.
How to Read Sterility and Endotoxin Results on a COA
| COA entry | What it may mean | What to verify |
|---|---|---|
| “Sterility: Pass” | No growth was detected in the tested sample under the stated method. | Method, sample quantity, media, incubation period, method suitability, and lot number |
| “No growth” | No visible or instrument-detected microbial growth was observed. | Whether the full required incubation period was completed and controls were valid |
| “Endotoxin: <0.10 EU/mg” | Endotoxin activity was below the method’s reporting threshold or stated value. | Specification, units, method, sample dilution, interference controls, and calculation basis |
| “BET: Complies” | The test result met the stated bacterial endotoxin criterion. | The actual limit and result, not only the word “complies” |
| “Pyrogen-free” | Often used imprecisely in marketing. | Which pyrogen test was performed and whether only bacterial endotoxin was evaluated |
| “Sterile and endotoxin-free” | A broad claim requiring separate supporting tests and process controls. | Lot-specific sterility and endotoxin reports, methods, limits, sampling, and manufacturing controls |
Specifications and results must both be visible
A COA should ideally show the method, predefined acceptance criterion, actual result, units, and conclusion. “Pass” without a disclosed limit provides less information than a numerical result compared against a defined specification.
| Test | Example specification | Example result | Interpretation |
|---|---|---|---|
| Sterility | No evidence of microbial growth | No growth detected | Meets the stated sterility-test criterion for the tested sample. |
| Bacterial endotoxins | Not more than 0.50 EU/mg | 0.08 EU/mg | Meets the stated endotoxin limit under the validated test conditions. |
Major Limitations of Final-Product Testing
Sterility testing is a sampling test
Because the test consumes the product, only selected units can be analyzed. Contamination may be nonuniform or sporadic. A contaminated vial can exist even when the sampled vials show no growth. Increasing the number of tested units improves sampling confidence but does not transform the test into proof of every unit.
Low-level contamination may be missed
A very small number of organisms may not be included in the sampled volume. Organisms may also be damaged, slow-growing, unevenly distributed, or unable to grow under the selected conditions. Product-related antimicrobial activity can suppress recovery if method suitability is inadequate.
Endotoxin assays are matrix-sensitive
Proteins, peptides, surfactants, salts, chelating agents, extreme pH, color, turbidity, and other sample characteristics can interfere with endotoxin detection. A result without suitable interference controls may be unreliable.
Endotoxin testing is not a universal pyrogen test
The bacterial endotoxins test is designed for bacterial endotoxins. Other substances can cause pyrogenic responses without being detected by a BET. Therefore, “low endotoxin” should not automatically be translated into “free of all pyrogens.”
Final testing cannot replace process control
A manufacturer cannot reliably test quality into a poorly controlled process. Sterility assurance and endotoxin control depend on facility hygiene, water systems, raw-material control, validated cleaning, equipment design, hold times, aseptic practices, sterilization, depyrogenation, environmental monitoring, packaging integrity, and trend analysis.
Bioburden Testing Is a Third, Separate Concept
Bioburden generally refers to the number and types of viable microorganisms present in or on a material before a sterilization step or as part of microbial-control monitoring. It is not the same as a sterility test and not the same as an endotoxin test.
| Test | Main question | Typical type of result |
|---|---|---|
| Sterility | Were viable organisms detected in the tested sample? | Growth or no growth |
| Endotoxin | How much bacterial endotoxin activity is present? | EU/mL, EU/mg, EU/device, or pass/fail |
| Bioburden | How many viable microorganisms are recoverable before sterilization or during monitoring? | Colony-forming units per defined amount |
Bioburden testing helps evaluate process hygiene and the microbial challenge presented to a sterilization or filtration process. A low bioburden does not prove sterility. A high bioburden may increase the risk of endotoxin accumulation, but bioburden counts do not directly quantify endotoxin.
Why organism identification can matter
The same colony count can carry different process implications depending on the organism. Repeated recovery of water-associated Gram-negative bacteria may point toward a water-system or wet-processing problem. Spore-forming organisms may challenge certain control strategies. Mold may suggest an environmental or facility issue. Trending the identity and location of isolates provides information that a total count alone cannot.
Endotoxin Testing vs. Pyrogen Testing
A pyrogen is a substance capable of producing a fever response. Bacterial endotoxins are an important category of pyrogens, but the terms are not identical. Non-endotoxin pyrogens can include components from Gram-positive bacteria, fungi, viruses, and other biological or chemical sources.
Bacterial endotoxin test
Targets endotoxin activity associated with Gram-negative bacterial lipopolysaccharide using lysate or recombinant reagent methods.
Broader pyrogen assessment
May be needed when non-endotoxin pyrogens are a plausible risk and the product or process cannot be adequately controlled using BET alone.
Claims such as “pyrogen-free” should therefore be examined carefully. A low BET result supports control of bacterial endotoxin under that method. It does not necessarily demonstrate absence of every pyrogenic substance.
Sampling, Batch Relevance, and Chain of Custody
Even technically valid results can be misleading when the sample is not connected to the distributed batch. A strong testing record identifies the exact lot, sample source, number of units, sample condition, collection date, receipt date, storage, and test date.
Questions to ask about sterility-test sampling
- Were finished vials or only bulk material tested?
- How many units were sampled?
- Were units selected across the filling or lyophilization run?
- Were different container sizes or sub-batches represented?
- Was the sample quantity sufficient for the compendial or validated method?
- Were the test units handled and transported under controlled conditions?
Questions to ask about endotoxin sampling
- Was the finished product tested, or only the bulk solution or raw powder?
- Did the test account for the product’s maximum valid dilution?
- Were interference and positive product controls acceptable?
- Were endotoxin-free sampling materials and containers used?
- Was the result reported in units appropriate to the specification?
- Did the lot number match the product being reviewed?
Finished-product results answer different questions from raw-material results
A raw peptide-powder endotoxin test may provide information about the starting material, but it does not establish the endotoxin status of finished vials after formulation, filling, lyophilization, capping, storage, and distribution. Similarly, a sterility result for a bulk solution does not automatically establish sterility of the final container.
How to Evaluate Sterility and Endotoxin Claims on a COA
- Match the lot. Confirm that the report’s lot or batch number matches the vial or product being evaluated.
- Identify the sample type. Determine whether the laboratory tested raw material, bulk solution, a finished vial, pooled vials, or multiple individual units.
- Find the exact method. Look for a compendial chapter, validated method number, or clear test description—not merely “microbial testing.”
- Review method suitability. Confirm that antimicrobial effects and endotoxin-assay interference were evaluated for the product matrix.
- Check specifications. A sterility result should have a clear no-growth criterion. An endotoxin result should have a numerical limit with units.
- Review actual results. Prefer the measured value and test conclusion over a single unexplained “pass” statement.
- Confirm controls were valid. Growth-promotion, negative controls, positive controls, standard curves, and product-control recovery must support test validity.
- Check dates. Sample receipt, testing, incubation completion, and report dates should follow a logical sequence.
- Verify the laboratory. Confirm the laboratory identity and report number independently when authenticity is uncertain.
- Keep claims separate. Do not allow a sterility result to substitute for endotoxin testing or an endotoxin result to substitute for sterility testing.
What a stronger microbiological testing packet includes
- Lot-specific finished-product testing
- Clear sample quantity and number of units
- Sterility method and complete incubation conditions
- Method-suitability or bacteriostasis/fungistasis information
- Endotoxin method, sensitivity, standard curve, and units
- Maximum valid dilution and interference-control results
- Actual specifications and measured results
- Authorized laboratory review and report identifier
- Separate bioburden or environmental-control data when relevant
- Evidence of broader sterility assurance rather than reliance on end-product testing alone
Misleading Claims and Red Flags
- “Sterile” based only on a sealed vial. Container appearance does not establish sterility.
- “Endotoxin-free” without a test result. The claim should be supported by a lot-specific method, limit, units, and actual result.
- A sterility result used to imply low endotoxin. No-growth testing does not measure endotoxin.
- An endotoxin result used to imply sterility. A BET does not detect viable yeast, mold, Gram-positive bacteria, or all Gram-negative bacteria as living organisms.
- “Pyrogen-free” based only on BET. BET is directed toward bacterial endotoxins, not necessarily all possible pyrogens.
- No method-suitability information. Product inhibition can hide microbial growth or endotoxin activity.
- No numerical endotoxin limit. “Pass” is difficult to evaluate without units and acceptance criteria.
- No lot match. A valid report for another batch is not evidence for the batch in hand.
- Raw-material testing presented as finished-vial testing. Later processing steps can introduce contamination.
- One sample described as proof of every vial. Sterility testing is limited by sampling.
- Testing performed immediately after inoculation. Sterility results require the complete specified incubation period unless a validated rapid method is used.
- Repeat testing used to erase a failure. An initial positive result requires a scientifically justified investigation.
- HPLC purity presented as microbiological testing. Chemical purity does not establish sterility or endotoxin status.
- “No bacteria” presented as “no endotoxin.” Dead or removed Gram-negative organisms can leave endotoxin behind.
Quick Comparison
| Question | Sterility test | Bacterial endotoxin test |
|---|---|---|
| Primary target | Viable microorganisms | Gram-negative bacterial endotoxin activity |
| Common result format | Growth / no growth | EU/mL, EU/mg, EU/device, or pass/fail |
| Can detect dead bacteria? | No, not as viable growth | Can detect remaining endotoxin activity from Gram-negative bacterial material |
| Can detect yeast or mold? | Yes, when recoverable under the test conditions | No |
| Can detect Gram-positive bacteria? | Yes, when viable and recoverable | Not through Gram-negative endotoxin detection |
| Can prove every vial is acceptable? | No; testing is based on sampled units | No; the result applies to the tested sample and method |
| Does passing prove safety? | No | No |
| Does passing prove identity or purity? | No | No |
Frequently Asked Questions
Can a sterile product contain endotoxin?
Yes. Sterility refers to viable microorganisms under the test and process context. Endotoxin can remain after Gram-negative bacteria have died or been removed. A separate bacterial endotoxins test is required to evaluate endotoxin activity.
Can a low-endotoxin product fail sterility testing?
Yes. Viable yeast, mold, Gram-positive bacteria, or even low-endotoxin Gram-negative contamination can produce a sterility failure while the BET remains below its specified limit.
Does autoclaving remove endotoxin?
Autoclaving is designed primarily to kill viable microorganisms. It should not be assumed to provide adequate depyrogenation. Endotoxin reduction requires a separately validated process appropriate to the material and equipment.
Is “no growth” the same as sterile?
“No growth” means no viable microorganisms were detected in the tested sample under the stated conditions. A sterile-product claim also depends on validated manufacturing controls, sampling, container integrity, environmental control, and the overall sterility-assurance system.
What does EU mean?
EU means endotoxin unit, a standardized measure of endotoxin activity. Results should always include the basis, such as EU/mL or EU/mg, and should be compared with a defined product-specific limit.
Is LAL the only endotoxin method?
Traditional compendial methods use amebocyte lysate reagents, including gel-clot, turbidimetric, and chromogenic approaches. USP Chapter <86> also provides techniques using recombinant reagents. Method suitability and the applicable regulatory framework remain essential.
What is recombinant Factor C?
Recombinant Factor C is a non-animal-derived reagent based on the endotoxin-sensitive initiating protein in the horseshoe-crab clotting cascade. When activated by endotoxin, it generates a measurable signal. Suitability must be established for the specific product and method.
Is endotoxin the same as all bacterial toxins?
No. Endotoxin refers specifically to lipopolysaccharide-associated material from Gram-negative bacteria. Bacteria can produce many other toxins that are not measured by a standard bacterial endotoxins test.
Does HPLC purity say anything about sterility?
No. HPLC evaluates chemical components detectable under a chromatographic method. It does not establish absence of viable microorganisms or bacterial endotoxin.
Why is the endotoxin limit different for different products?
Limits can depend on the route of exposure, maximum dose or contact, product concentration, patient population, and applicable compendial or regulatory requirements. A number cannot be judged without its units and product-specific specification.
Can a clear solution still fail either test?
Yes. Microorganisms and endotoxin may be present without visible cloudiness, particles, color, or odor. Visual appearance cannot replace microbiological testing.
Does one sterile test prove the entire batch is sterile?
No. The result directly applies to the sampled units. Batch assurance depends on representative sampling and a validated, consistently controlled manufacturing and packaging process.
Final Takeaway
Sterility testing and bacterial endotoxin testing are complementary, not interchangeable. Sterility testing is designed to detect viable microorganisms in a sample under defined growth conditions. Endotoxin testing detects or quantifies a specific type of pyrogenic bacterial material associated with Gram-negative bacteria.
A sample can pass sterility and fail endotoxin because dead bacteria can leave endotoxin behind. It can pass endotoxin and fail sterility because viable yeast, mold, or other bacteria may be present without producing a high BET result. Both tests also have sampling, interference, detection, and method-suitability limitations.
Remember: “No growth” answers a viable-microorganism question. “Below the endotoxin limit” answers a bacterial-endotoxin question. Neither result can substitute for the other, and neither result alone proves overall product quality or suitability for human use.
Technical References and Further Reading
- U.S. Food and Drug Administration. Pyrogen and Endotoxins Testing: Questions and Answers. Updated March 18, 2026. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pyrogen-and-endotoxins-testing-questions-and-answers
- U.S. Food and Drug Administration. Pharmaceutical Microbiology Manual. https://www.fda.gov/media/88801/download
- United States Pharmacopeia. USP General Chapter <71> Sterility Tests. Listed among USP injectables-related documentary standards. https://www.usp.org/biologics/injectables
- United States Pharmacopeia. USP General Chapter <85> Bacterial Endotoxins Test. https://www.usp.org/harmonization-standards/pdg/general-methods/bacterial-endotoxins
- United States Pharmacopeia. USP General Chapter <86> Bacterial Endotoxins Test Using Recombinant Reagents. Official May 2025. https://www.usp.org/news/chapter-for-endotoxin-testing-using-non-animal-derived-reagents-published-for-early-adoption
- U.S. Food and Drug Administration. Bacterial Endotoxins/Pyrogens Inspection Technical Guide. https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/inspection-technical-guides/bacterial-endotoxinspyrogens
- U.S. Food and Drug Administration. Container and Closure System Integrity Testing in Lieu of Sterility Testing as a Component of the Stability Protocol. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/container-and-closure-system-integrity-testing-lieu-sterility-testing-component-stability-protocol
- European Medicines Agency. ICH Q4B Annex 14: Bacterial Endotoxins Tests. https://www.ema.europa.eu/en/ich-q4b-annex-14-bacterial-endotoxins-tests-scientific-guideline
- European Medicines Agency. Guideline on the Sterilisation of the Medicinal Product, Active Substance, Excipient and Primary Container. https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-sterilisation-medicinal-product-active-substance-excipient-and-primary-container_en.pdf
- European Medicines Agency. Quality of Medicines Questions and Answers—Endotoxin and Sterility Testing at End of Shelf Life. https://www.ema.europa.eu/en/human-regulatory-overview/research-development/scientific-guidelines/quality-medicines-questions-answers-introduction/quality-medicines-questions-answers-part-2